INVESTIGATIONAL NEW DRUGS

期刊名
INVESTIGATIONAL NEW DRUGS

INVEST NEW DRUG

ISSN / eISSN
0167-6997 / 1573-0646
目标和范围
The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.
研究方向

药学

肿瘤学

CiteScore
6.80 查看趋势图
CiteScore 学科排名
类别 分区 排名
Medicine - Pharmacology (medical) Q1 #51/260
Medicine - Oncology Q2 #104/366
Medicine - Pharmacology Q2 #93/301
Web of Science 核心收藏夹
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2023) 分区
ONCOLOGY - SCIE Q3
PHARMACOLOGY & PHARMACY - SCIE Q2
H-index
80
出版国家或地区
UNITED STATES
出版商
Springer US
出版周期
Quarterly
出版年份
1983
年文章数
112
Open Access
NO
通讯方式
SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
How much is the layout fee?
2021-04-07

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started